Longitudinal study on Plasmodium falciparum gametocyte carriage following artemether-lumefantrine administration in a cohort of children aged 12-47 months living in Western Kenya, a high transmission area

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Andagalu, Ben ^a   Mativo, Joan ^a   Kamau, Edwin ^a   Ogutu, Bernhards ^a  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

Artemether lumefantrine; Asymptomatic children; Epidemiological study; Gametocytes; Longitudinal study; Western Kenya

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; PLACEBO; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DRUG COMBINATION; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ARTICLE; CHILD; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; FEMALE; GAMETOCYTE; HUMAN; KENYA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; OUTCOME ASSESSMENT; PARASITE LOAD; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; COHORT ANALYSIS; DRUG COMBINATION; DRUG THERAPY; EPIDEMIOLOGY; HETEROZYGOTE; INFANT; ISOLATION AND PURIFICATION; MALARIA, FALCIPARUM; PARASITEMIA; PARASITOLOGY; PRESCHOOL CHILD;

ANTIMALARIALS; ARTEMISININS; CARRIER STATE; CHILD, PRESCHOOL; COHORT STUDIES; DRUG COMBINATIONS; EPIDEMIOLOGIC STUDIES; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INFANT; KENYA; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MALE; PARASITEMIA; PLACEBOS; PLASMODIUM FALCIPARUM;

EID: 84903871060     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-265     Document Type: Article

References (46)

1. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Bousema T, Drakeley C, Clin Microbiol Rev 2011 24 377 410 10.1128/CMR.00051-10 21482730
2. Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria? Ogutu B, Tiono AB, Makanga M, Premji Z, Gbadoe AD, Ubben D, Marrast AC, Gaye O, Malar J 2010 9 30 10.1186/1475-2875-9-30 20096111
3. A country-wide malaria survey in Mozambique. II. Malaria attributable proportion of fever and establishment of malaria case definition in children across different epidemiological settings. Mabunda S, Aponte JJ, Tiago A, Alonso P, Malar J 2009 8 74 10.1186/1475-2875-8-74 19383126
4. A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso. Tiono A, Ouedraogo A, Ogutu B, Diarra A, Coulibaly S, Gansane A, Sirima S, O'Neil G, Mukhopadhyay A, Hamed K, Malar J 2013 12 79 10.1186/1475-2875-12-79 23442748
5. The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. Drakeley C, Sutherland C, Bousema JT, Sauerwein RW, Targett GA, Trends Parasitol 2006 22 424 430 10.1016/j.pt.2006.07.001 16846756 (Pubitemid 44176410)
6. A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya. Mens PF, Sawa P, van Amsterdam SM, Versteeg I, Omar SA, Schallig HD, Kager PA, Malar J 2008 7 237 10.1186/1475-2875-7-237 19017387
7. (Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate. Schneider P, Bousema T, Omar S, Gouagna L, Sawa P, Schallig H, Sauerwein R, Int J Parasitol 2006 36 403 408 10.1016/j.ijpara.2006.01.002 16500657 (Pubitemid 43744427)
8. Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification. Schneider P, Schoone G, Schallig H, Verhage D, Telgt D, Eling W, Sauerwein R, Mol Biochem Parasitol 2004 137 35 41 10.1016/j.molbiopara.2004.03.018 15279949 (Pubitemid 38987940)
9. Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission. Ouedraogo AL, Bousema T, Schneider P, de Vlas SJ, Ilboudo-Sanogo E, Cuzin-Ouattara N, Nebie I, Roeffen W, Verhave JP, Luty AJ, Sauerwein R, PLoS One 2009 4 8410 10.1371/journal.pone.0008410 20027314
10. Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Schneider P, Bousema JT, Gouagna LC, Otieno S, van de Vegte-Bolmer M, Omar SA, Sauerwein RW, Am J Trop Med Hyg 2007 76 470 474 17360869 (Pubitemid 351627738)
11. Estimates of the infectious reservoir of Plasmodium falciparum malaria in The Gambia and in Tanzania. Drakeley CJ, Akim NI, Sauerwein RW, Greenwood BM, Targett GA, Trans R Soc Trop Med Hyg 2000 94 472 476 10.1016/S0035-9203(00) 90056-7 11132369
12. The reservoir of Plasmodium falciparum malaria in a holoendemic area of western Kenya. Githeko AK, Brandling-Bennett AD, Beier M, Atieli F, Owaga M, Collins FH, Trans R Soc Trop Med Hyg 1992 86 355 358 10.1016/0035-9203(92)90216- Y 1359683
13. A country-wide malaria survey in Mozambique. I. Plasmodium falciparum infection in children in different epidemiological settings. Mabunda S, Casimiro S, Quinto L, Alonso P, Malar J 2008 7 216 10.1186/1475-2875-7-216 18950486
14. Altitude-dependent and -independent variations in Plasmodium falciparum prevalence in northeastern Tanzania. Drakeley CJ, Carneiro I, Reyburn H, Malima R, Lusingu JP, Cox J, Theander TG, Nkya WM, Lemnge MM, Riley EM, J Infect Dis 2005 191 1589 1598 10.1086/429669 15838785 (Pubitemid 40656746)
15. Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. Mwangi TW, Ross A, Snow RW, Marsh K, J Infect Dis 2005 191 1932 1939 10.1086/430006 15871128 (Pubitemid 40705402)
16. Plasmodium falciparum and P. malariae epidemiology in a West African village. Boudin C, Robert V, Verhave JP, Carnevale P, Ambroise-Thomas P, Bull World Health Organ 1991 69 199 205 1677615
17. Spatial and temporal variation in malaria transmission in a low endemicity area in northern Tanzania. Oesterholt MJ, Bousema JT, Mwerinde OK, Harris C, Lushino P, Masokoto A, Mwerinde H, Mosha FW, Drakeley CJ, Malar J 2006 5 98 10.1186/1475-2875-5-98 17081311 (Pubitemid 44730496)
18. Seasonal patterns of Plasmodium falciparum gametocyte prevalence and density in a rural population of Burkina Faso. Ouedraogo AL, de Vlas SJ, Nebie I, Ilboudo-Sanogo E, Bousema JT, Ouattara AS, Verhave JP, Cuzin-Ouattara N, Sauerwein RW, Acta Trop 2008 105 28 34 10.1016/j.actatropica.2007.09.003 17964522 (Pubitemid 350262801)
19. Genetic variation in human HBB is associated with Plasmodium falciparum transmission. Gouagna LC, Bancone G, Yao F, Yameogo B, Dabire KR, Costantini C, Simpore J, Ouedraogo JB, Modiano D, Nat Genet 2010 42 328 331 10.1038/ng.554 20305663
20. Heritability of the human infectious reservoir of malaria parasites. Lawaly YR, Sakuntabhai A, Marrama L, Konate L, Phimpraphi W, Sokhna C, Tall A, Sarr FD, Peerapittayamongkol C, Louicharoen C, Schneider BS, Levescot A, Talman A, Casademont I, Menard D, Trape JF, Rogier C, Kaewkunwal J, Sura T, Nuchprayoon I, Ariey F, Baril L, Singhasivanon P, Mercereau-Puijalon O, Paul R, PLoS One 2010 5 11358 10.1371/journal.pone.0011358 20613877
21. Genetic complexity and gametocyte production of Plasmodium falciparum in Fulani and Mossi communities in Burkina Faso. Paganotti GM, Palladino C, Modiano D, Sirima BS, Raberg L, Diarra A, Konate A, Coluzzi M, Walliker D, Babiker HA, Parasitology 2006 132 607 614 16420718
22. A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. von Seidlein L, Bojang K, Jones P, Jaffar S, Pinder M, Obaro S, Doherty T, Haywood M, Snounou G, Gemperli B, Gathmann I, Royce C, McAdam K, Greenwood B, Am J Trop Med Hyg 1998 58 638 644 9598454 (Pubitemid 28237264)
23. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Price R, Nosten F, Simpson JA, Luxemburger C, Phaipun L, ter Kuile F, van Vugt M, Chongsuphajaisiddhi T, White NJ, Am J Trop Med Hyg 1999 60 1019 1023 10403336 (Pubitemid 29296230)
24. Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Stepniewska K, Price RN, Sutherland CJ, Drakeley CJ, von Seidlein L, Nosten F, White NJ, Malar J 2008 7 249 10.1186/1475-2875-7-249 19055751
25. Increased Plasmodium falciparum gametocyte production in mixed infections with P. malariae. Bousema JT, Drakeley CJ, Mens PF, Arens T, Houben R, Omar SA, Gouagna LC, Schallig H, Sauerwein RW, Am J Trop Med Hyg 2008 78 442 448 18337341 (Pubitemid 351845195)
26. Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali. Beavogui AH, Djimde AA, Gregson A, Toure AM, Dao A, Coulibaly B, Ouologuem D, Fofana B, Sacko A, Tekete M, Kone A, Niare O, Wele M, Plowe CV, Picot S, Doumbo OK, Int J Parasitol 2010 40 1213 1220 10.1016/j.ijpara.2010.04.010 20460125
27. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Bousema JT, Gouagna LC, Drakeley CJ, Meutstege AM, Okech BA, Akim IN, Beier JC, Githure JI, Sauerwein RW, Malar J 2004 3 18 10.1186/1475-2875-3- 18 15202944 (Pubitemid 39319755)
28. Observations on the natural history of malaria in the semi-resistant West African. Miller MJ, Trans R Soc Trop Med Hyg 1958 52 152 168 10.1016/0035-9203(58)90036-1 13543904
29. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. Barnes KI, Chanda P, Ab Barnabas G, Malar J 2009 12 8
30. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal South Africa. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E, Dlamini SS, Tsoka J, Bredenkamp B, Mthembu DJ, White NJ, Sharp BL, PLoS Med 2005 2 330 10.1371/journal.pmed.0020330 16187798 (Pubitemid 41735780)
31. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. Bhattarai A, Ali AS, Kachur SP, Martensson A, Abbas AK, Khatib R, Al-Mafazy AW, Ramsan M, Rotllant G, Gerstenmaier JF, Molteni F, Abdulla S, Montgomery SM, Kaneko A, Björkman A, PLoS Med 2007 4 309 10.1371/journal.pmed.0040309 17988171 (Pubitemid 350220531)
32. Effects of artemisinin derivatives on malaria transmissibility. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ, Lancet 1996 347 1654 1658 10.1016/S0140-6736(96)91488-9 8642959 (Pubitemid 26177386)
33. The effects of ACT treatment and TS prophylaxis on Plasmodium falciparum gametocytemia in a cohort of young Ugandan children. Kakuru A, Jagannathan P, Arinaitwe E, Wanzira H, Muhindo M, Bigira V, Osilo E, Homsy J, Kamya MR, Tappero JW, Dorsey G, Am J Trop Med Hyg 2013 88 736 743 10.4269/ajtmh.12-0654 23382157
34. Plasmodium falciparum gametocytes in Gambian adults. Drakeley CJ, Flobbe K, Greenwood BM, Targett GA, Ann Trop Med Parasitol 2000 94 399 401 10945050 (Pubitemid 30410183)
35. Plasmodium falciparum gametocytes: their longevity and infectivity. Smalley ME, Sinden RE, Parasitology 1977 74 1 8 10.1017/S0031182000047478 320542 (Pubitemid 8016153)
36. Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda. Mwesigwa J, Parikh S, McGee B, German P, Drysdale T, Kalyango JN, Clark TD, Dorsey G, Lindegardh N, Annerberg A, Rosenthal PJ, Kamya MR, Aweeka F, Antimicrob Agents Chemother 2009 54 52 59 19841149
37. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Arinaitwe E, Sandison TG, Wanzira H, Kakuru A, Homsy J, Kalamya J, Kamya MR, Vora N, Greenhouse B, Rosenthal PJ, Tappero J, Dorsey G, Clin Infect Dis 2009 49 1629 1637 10.1086/647946 19877969
38. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Zongo I, Dorsey G, Rouamba N, Dokomajilar C, Sere Y, Rosenthal PJ, Ouedraogo JB, Clin Infect Dis 2007 45 1453 1461 10.1086/522985 17990228 (Pubitemid 351411875)
39. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. Kamya MR, Yeka A, Bukirwa H, Lugemwa M, Rwakimari JB, Staedke SG, Talisuna AO, Greenhouse B, Nosten F, Rosenthal PJ, Wabwire-Mangen F, Dorsey G, PLoS Clin Trials 2007 2 20 10.1371/journal.pctr. 0020020 17525792 (Pubitemid 46860146)
40. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. Yeka A, Dorsey G, Kamya MR, Talisuna A, Lugemwa M, Rwakimari JB, Staedke SG, Rosenthal PJ, Wabwire-Mangen F, Bukirwa H, PLoS One 2008 3 2390 10.1371/journal.pone.0002390 18545692
41. Early gametocytes of the malaria parasite Plasmodium falciparum specifically remodel the adhesive properties of infected erythrocyte surface. Tiburcio M, Silvestrini F, Bertuccini L, Sander AF, Turner L, Lavstsen T, Alano P, Cell Microbiol 2012 http://dx.doi.org/10.1111/cmi.12062
42. Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. Bassat Q, Mulenga M, Tinto H, Piola P, Borrmann S, Menendez C, Nambozi M, Valea I, Nabasumba C, Sasi P, Bacchieri A, Corsi M, Ubben D, Talisuna A, D'Alessandro U, PLoS One 2009 4 7871 10.1371/journal.pone.0007871 19936217
43. Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children. Nambozi M, Van Geertruyden JP, Hachizovu S, Chaponda M, Mukwamataba D, Mulenga M, Ubben D, D'Alessandro U, Malar J 2011 10 50 10.1186/1475-2875-10-50 21352609
44. Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial. Sawa P, Shekalaghe SA, Drakeley CJ, Sutherland CJ, Mweresa CK, Baidjoe AY, Manjurano A, Kavishe RA, Beshir KB, Yussuf RU, Omar SA, Hermsen CC, Okell L, Schallig HD, Sauerwein RW, Hallett RL, Bousema T, J Infect Dis 2013 207 1637 1645 10.1093/infdis/jit077 23468056
45. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung RM, Laihad F, Ebsworth EP, Anstey NM, Tjitra E, Price RN, Lancet 2007 369 757 765 10.1016/S0140-6736(07)60160-3 17336652 (Pubitemid 46335820)
46. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. Bousema JT, Schneider P, Gouagna LC, Drakeley CJ, Tostmann A, Houben R, Githure JI, Ord R, Sutherland CJ, Omar SA, Sauerwein RW, J Infect Dis 2006 193 1151 1159 10.1086/503051 16544256